Supporting the science behind protein structure and function.
Proteomics is concerned with protein structure and function. We support facilities offering a broad range of services including high throughput proteomics, protein biochemistry, monoclonal antibody production, along with drug discovery and screening.
Our facilities host the latest in mass spectrometry, Amino Acid Analysis and N-Terminal sequencing technology and are staffed by leading national practitioners.
The Bioplatforms proteomics network is a national fabric of leading practitioners, each with unique technologies that together ensure researchers have access to a comprehensive suite of proteomics capabilities.
Our Proteomics Facilities
The Australian Proteome Analysis Facility (APAF) provides academic and corporate clients with modern functional proteomics and protein chemistry tools integrated with in-house and commercial bioinformatics toolkits. The facility has a mixed portfolio of activity including contract analysis, collaborative applied and fundamental research, and technology development to industry, government and the research community.
APAF provides high throughput, quality, national and international proteomics and protein chemistry research services.
Monash Proteomics & Metabolomics Facility (MPMF) and Monash Antibody Technologies Facility (MATF) provide services for antibody discovery, antibody production, antibody sequencing and cell line cryopreservation. The primary focus in the core is generating high-affinity monoclonal antibodies that are specific for the customer’s needs. Their scientist team also has expertise in more advanced techniques for antibody characterisation SPR, alternative antibody formats, humanisation and affinity maturation techniques
Our facility at the University of South Australia is world leader in mass spectrometry based imaging, providing critical collaborative services for spatial mapping of protein distribution. Together with an offering of classical qualitative and quantitative proteomics, the UniSA facility provides substantial industrial and commercial partnership.
Proteomics International is a pioneering medical technology company operating at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and function of proteins.
Proteomics International’s aim is to use its expertise in proteins to develop and commercialise diagnostic tests for chronic diseases where there is unmet medical need.
Proteomics International has entered a Private Public partnership with the University of Western Australia who compliment the proteomics offering with leading national plant science capability and functional protein assessment.